Development of Brimonidine-Loaded Ethosomes for Glaucoma: Investigation of Intraocular Pressure-Lowering Potential In Vivo

<b>Background/Objectives</b>: Brimonidine tartrate (BRT), a selective α2-adrenergic receptor agonist, is commonly used in the treatment of glaucoma. However, conventional eye drop formulations suffer from poor ocular bioavailability and rapid elimination. This study aimed to develop and evaluate BRT...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Samet Özdemir, Ali Asram Sağıroğlu, Eslim Şen, Büşra Gelmez Yıldız, Laman Karimli, Meltem Ezgi Durgun Kılıç, Ali Riza Cenk Celebi, Yıldız Özsoy
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2026-02-01
סדרה:	Pharmaceutics
נושאים:	brimonidine tartrate ethosomes HET-CAM intraocular pressure glaucoma ophthalmic drug delivery
גישה מקוונת:	https://www.mdpi.com/1999-4923/18/2/210
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!